Verified stock metrics
Kalaris Therapeutics Key Stock Metrics
Direct answer
Kalaris Therapeutics has 7 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked October 12, 2026.
Get free Kalaris Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Market capitalization
- $53.16M
- Price-to-book ratio
- 0.92x
- Return on equity
- -79.91%
- Dividend yield
- 0%
- 52-week price range
- $2.23 to $11.88
- Profit margin
- 0%
- Debt-to-equity ratio
- 2.43%
Explore related company data
View Kalaris Therapeutics's market capitalizationView Kalaris Therapeutics's price-to-book ratioView Kalaris Therapeutics's return on equityView Kalaris Therapeutics's dividend yieldView Kalaris Therapeutics's 52-week price rangeView Kalaris Therapeutics's profit marginView Kalaris Therapeutics's debt-to-equity ratioReturn to Kalaris Therapeutics profile